Could IgE immunoglobulins have a beneficial function against cancer as well as their harmful function in allergy? Could this beneficial function be used in the development of new cancer therapies? The emerging field of AllergoOncology seeks to answer these questions. In this work, international contributors present current research exploring the association of IgE antibodies and cancer. After a review of the biology of IgE, epidemiological evidence, and mast cells in allergy and tumor disease, the book discusses the IgE antibody and its use in cancer immunotherapy, IgE as an adjuvant in tumor vaccination, allergen-associated and tumor-associated molecular patterns, and the role of Th2-mediated anti-tumor immunity in tumor surveillance and clearance. Color illustrations and images are included. Penichet is affiliated with the Molecular Biology Institute the University of California-Los Angeles. Jensen-Jarolim is affiliated with the Department of Pathophysiology at the Medical University of Vienna, Austria. Annotation ©2010 Book News, Inc., Portland, OR (booknews.com)